Life Sciences AISeries EInfraℹOpentrons
The physical execution layer for autonomous science.
Company snapshot
- Stage
- Series E
- Funding
- Series E · $40M · Oct 29, 2026
- Status
- published
- Updated
- Nov 8, 2026
- Views
- Category
- Life Sciences AI
- Website
- opentrons.com
What they're building
The physical execution layer for autonomous science. Opentrons connects AI models to open laboratory robots, turning experiment design, execution, and structured results into a continuous learning loop for autonomous science.
Founders
William Canine
Co-founder
Chiu Chau
Co-founder
Nicholas Wagner
Co-founder (former)
Foundation model usage
Editorial estimates from product descriptions. Model providers and actual usage are not confirmed.
- Inferred architecture
- Agentic loops
- Estimated model demand
- High intensity
NYC footprint
- Documented NYC location
- 45-18 Court Square West, Long Island City, NY 11101 · Current occupancy not confirmed; see sources below.
Funding
Latest funding: Series E · $40M · Oct 29, 2026. Lead investor: Avego.
Sources & location evidence
Open research desk ↗Profile source review: 2026-11-04. Current AI product, canonical identity, active operations and NYC presence. Funding not rechecked unless a linked funding correction is recorded. Current independent company, Opentrons Labworks Inc. October 29, 2026 primary release verifies $40M Series E led by Avego and explicitly NYC headquarters. Current Flex docs resolve office at 45-18 Court Square West in Long Island City, Queens. AI is now core strategy: AI designs, runs and improves experiments on open robots; distinguish from pure software companies. Current CEO is James Atwood, not cofounder William Canine or former CEO Jon Brennan-Badal. YC lists all three founders; current company leadership identifies Canine and Chau as cofounders. Aggregate total funding omitted.
- https://opentrons.com/ ↗
- https://opentrons.com/about/about-us ↗
- https://opentrons.com/archives/news/opentrons-announces-40m-series-e-round-to-standardize-ai-driven-science-on-its-robots ↗
- https://docs.opentrons.com/flex/support/ ↗
- https://www.ycombinator.com/companies/opentrons ↗
Long Island City, Queens · verified headquarters
45-18 Court Square West, Long Island City, NY 11101. Current occupancy not confirmed. Primary product documentation supplies office business information and office hours. Long Island City is named directly. October 29, 2026 company release calls it open AI-native laboratory automation and explicitly states NYC headquarters. Do not use its old 20 Jay Street Brooklyn address.
Opentrons Flex: Support and Contact Information ↗Source checked 2026-11-03
Notes
Opentrons is tagged infra based on buyer clarity, repeat workflow activity, public activity, and fit with the AI Atlas map.
Related NYC startups
Proxima Bio, formerly VantAI, is an AI-native platform for proximity-based drug discovery, mapping protein-protein interactions to design medicines that reshape protein networks rather than inhibit single targets.
Life Sciences AIWorkflowℹRecent Activity
Scientific AI can become more useful by learning the mechanisms behind complex systems and using those explanations to guide new investigations.
Output Labs develops AI systems for mechanistic reasoning, aiming to model how complex systems work and apply those explanations to scientific problems.
Life Sciences AIWorkflowℹRecent Activity
Find therapeutic targets hidden in RNA splicing.
Envisagenics analyzes RNA splicing with AI to identify disease-specific drug targets, advancing therapeutic discovery for cancer and neurodegenerative conditions through its SpliceCore platform.
Life Sciences AIInfraℹRecent Activity